- Home
- ANNX vs SMTI Comparison
ANNX vs SMTI Comparison
Compare ANNX & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- SMTI
- Stock Information
- Founded
- ANNX 2011
- SMTI 1982
- Country
- ANNX United States
- SMTI United States
- Employees
- ANNX N/A
- SMTI N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- ANNX Health Care
- SMTI Health Care
- Exchange
- ANNX Nasdaq
- SMTI Nasdaq
- Market Cap
- ANNX 253.8M
- SMTI 243.3M
- IPO Year
- ANNX 2020
- SMTI N/A
- Fundamental
- Price
- ANNX $2.06
- SMTI $33.66
- Analyst Decision
- ANNX Strong Buy
- SMTI Strong Buy
- Analyst Count
- ANNX 5
- SMTI 2
- Target Price
- ANNX $13.00
- SMTI $50.00
- AVG Volume (30 Days)
- ANNX 1.2M
- SMTI 40.9K
- Earning Date
- ANNX 08-14-2025
- SMTI 08-13-2025
- Dividend Yield
- ANNX N/A
- SMTI N/A
- EPS Growth
- ANNX N/A
- SMTI N/A
- EPS
- ANNX N/A
- SMTI N/A
- Revenue
- ANNX N/A
- SMTI $97,241,894.00
- Revenue This Year
- ANNX N/A
- SMTI $24.49
- Revenue Next Year
- ANNX N/A
- SMTI $14.43
- P/E Ratio
- ANNX N/A
- SMTI N/A
- Revenue Growth
- ANNX N/A
- SMTI 34.29
- 52 Week Low
- ANNX $1.29
- SMTI $23.53
- 52 Week High
- ANNX $7.85
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- ANNX 38.44
- SMTI 66.25
- Support Level
- ANNX $2.06
- SMTI $29.33
- Resistance Level
- ANNX $2.36
- SMTI $34.10
- Average True Range (ATR)
- ANNX 0.17
- SMTI 1.54
- MACD
- ANNX -0.03
- SMTI 0.48
- Stochastic Oscillator
- ANNX 1.52
- SMTI 90.30
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.